In ALI, COPD, asthma, PAH and PF, FMN consistently has dual effects: enhancing the antioxidant Nrf2/HO-1 pathway and suppressing NF-κB–mediated cytokine activity. Here, NFKB1 is linked to acute respiratory distress syndrome.